Current updates on bone grafting biomaterials and recombinant human growth factors implanted biotherapy for spinal fusion: A review of human clinical studies.

CONCLUSION: Selection of a particular bone grafting biotherapy can be rationalized based on level of spine fusion, clinical experience and preference of orthopaedic surgeon, and prevalence of donor-site morbidities. PMID: 30360738 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30360738?dopt=Abstract

Source: Current Drug Delivery - October 24, 2018 Category: Drugs & Pharmacology Authors: Li G, Li P, Chen Q, Thu HE, Hussain Z Tags: Curr Drug Deliv Source Type: research